Save time and jump to the most important pieces.
Salt Lake City, Utah, Oct. 01, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company") an advanced materials company specializing in ceramics for biomedical, aerospace, and industrial applications, is pleased to announce two key executive promotions. Effective immediately Ryan Bock, PhD has been promoted to Chief Technology Officer (CTO) of SINTX Technologies, Inc., and Ann Kutsch has been promoted to President of SINTX Technology Assessment and Transfer (SINTX TA&T), a subsidiary of SINTX. As CTO, Dr. Bock will lead the strategic development of SINTX's advanced materials technologies and innovation pipeline. Dr. Bock has been with SINTX since 2008,
Salt Lake City, Utah, Sept. 20, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company") a leader in advanced ceramics, and Prodways, a global specialist in 3D printing solutions, are excited to announce their jointly sponsored webinar: "Innovations in Ceramic Manufacturing: The Role of 3D Printing." This live webinar, organized in partnership with TCT Magazine, will take place on September 24th at 9:00 AM EDT/3:00 PM CEST. The event is tailored for industry professionals eager to explore the transformative impact of additive manufacturing (AM) on ceramic applications. Experts from SINTX and Prodways will delve into the latest advancements in 3D printing
Salt Lake City, Utah, Sept. 19, 2024 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ:SINT) ("SINTX" or the "Company") a leading innovator in ceramic manufacturing, today announced the successful completion of its previously announced "at-the-market" equity public offering (the "ATM Program") which provided for the offer and sale, from time to time, of shares of its common stock (the "Shares") having an aggregate sales price of up to $3.12 million. The Company received aggregate gross proceeds of $3.11 million through the sale of 595,560 shares, at an average share price of $5.23 per share, resulting in total net proceeds to the Company of $3.05 million. There was no warrant coverage
4 - Sintx Technologies, Inc. (0001269026) (Issuer)
8-K - Sintx Technologies, Inc. (0001269026) (Filer)
8-K - Sintx Technologies, Inc. (0001269026) (Filer)
10-Q - Sintx Technologies, Inc. (0001269026) (Filer)
SC 13G - Sintx Technologies, Inc. (0001269026) (Subject)
SC 13G/A - Sintx Technologies, Inc. (0001269026) (Subject)
SC 13G - Sintx Technologies, Inc. (0001269026) (Subject)
The Acquisition Broadens Opportunities for SINTX in Aerospace, Defense, and Biomedical Markets SALT LAKE CITY, July 06, 2022 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics, announced the acquisition of Technology Assessment and Transfer, Inc. (TA&T; https://www.techassess.com/), significantly increasing SINTX's capabilities in the aerospace, defense, and biomedical markets. "We are excited to acquire TA&T and take another step towards diversifying and strengthening SINTX," said Dr. Sonny Bal, President and CEO of SINTX. "TA&T will expand our use of advanced manufacturing techno
SALT LAKE CITY, March 25, 2022 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) ("SINTX" or the "Company"), an original equipment manufacturer of advanced ceramics, announced today the filing of its Annual Report on Form 10-K for the year ended December 31, 2021 with the U.S. Securities and Exchange Commission. In 2021, SINTX made significant investments into the expansion of its three priority business segments - biomedical, industrial/armor, and antipathogenic - through the purchase of new technology, equipment, and personnel. The Company is narrowly focused on opportunities closest to revenue such as armor materials and plates, the development of new biomedi
SALT LAKE CITY, June 30, 2021 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (www.sintx.com) (NASDAQ:SINT) ("SINTX" or the "Company"), an original equipment manufacturer of silicon nitride ceramic for medical and non-medical applications, announced today it has moved into the next phase of its relationship with O2TODAY and sold the first shipment of FleX SN-AP antipathogenic silicon nitride powder to O2TODAY for integration into a proprietary line of masks and filters. "O2TODAY announced on its website today that it is taking limited pre-orders for masks and mask filters integrated with SINTX's antipathogenic powder," said Dr. Sonny Bal, President and CEO at SINTX Technologies. "We share th